METTL14-mediated m6A modification enhances USP22-ERα axis to drive breast cancer malignancy
Xuefen Zhuang(Guangzhou Medical University Cancer Hospital), Yuning Liao(Guangzhou Medical University), Gengxi Cai(First People's Hospital of Foshan), Yu Yao(Qinghai University), Xiaoyue He(Guangzhou Medical University), Cheng Ji(Guangzhou Medical University Cancer Hospital), Zirui Fang(Kingmed Diagnostics), E-ying Peng(Guangzhou Medical University), Yuting Li(Guangzhou Medical University), Yujie Xiang(Guangzhou Medical University), Lu Li(Guangzhou Medical University), Wenshuang Sun(Guangzhou Medical University Cancer Hospital), Hongbiao Huang(Harbin Institute of Technology), Shusha Yin(Guangzhou Medical University Cancer Hospital), Yuanfei Deng(First People's Hospital of Foshan)
Cited by 16
Related Papers
CGCG clinical practice guidelines for the management of adult diffuse gliomas
|Cancer Letters|2016|650
Clinical practice guidelines for the management of adult diffuse gliomas
|Cancer Letters|2020|482
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis
|The Lancet Oncology|2016|374
Temozolomide-associated hypermutation in gliomas
|Neuro-Oncology|2018|227
Adult IDH wild-type lower-grade gliomas should be further stratified
|Neuro-Oncology|2017|222